BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21554699)

  • 1. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
    Argraves KM; Sethi AA; Gazzolo PJ; Wilkerson BA; Remaley AT; Tybjaerg-Hansen A; Nordestgaard BG; Yeatts SD; Nicholas KS; Barth JL; Argraves WS
    Lipids Health Dis; 2011 May; 10():70. PubMed ID: 21554699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
    Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
    Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
    Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
    Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
    Polzin A; Piayda K; Keul P; Dannenberg L; Mohring A; Gräler M; Zeus T; Kelm M; Levkau B
    J Mol Cell Cardiol; 2017 Sep; 110():35-37. PubMed ID: 28709768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.
    Książek M; Baranowska U; Chabowski A; Baranowski M
    Cell Physiol Biochem; 2018; 45(1):67-77. PubMed ID: 29316552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.
    Soltau I; Mudersbach E; Geissen M; Schwedhelm E; Winkler MS; Geffken M; Peine S; Schoen G; Debus ES; Larena-Avellaneda A; Daum G
    PLoS One; 2016; 11(12):e0168302. PubMed ID: 27973607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Serum Sphingolipids in Andean Children Born and Living at High Altitude (3775 m).
    Barbacini P; Casas J; Torretta E; Capitanio D; Maccallini G; Hirschler V; Gelfi C
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
    Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
    Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
    Kimura T; Okajima F; Murakami M
    Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
    Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
    J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.
    Książek M; Charmas M; Klusiewicz A; Zabielski P; Długołęcka B; Chabowski A; Baranowski M
    Scand J Med Sci Sports; 2018 Jan; 28(1):57-64. PubMed ID: 28493600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.
    Argraves KM; Gazzolo PJ; Groh EM; Wilkerson BA; Matsuura BS; Twal WO; Hammad SM; Argraves WS
    J Biol Chem; 2008 Sep; 283(36):25074-81. PubMed ID: 18606817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
    Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
    Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
    Jing XD; Wei XM; Deng SB; Du JL; Liu YJ; She Q
    Clin Chim Acta; 2015 Jun; 446():248-52. PubMed ID: 25958848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
    Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
    Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.